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INTRODUCTION
Giant cell tumor (GCT) is a benign, locally aggressive
bone tumor that usually affects the metaphysis and the
epiphysis of long tubular bones. It is most frequently located
around the knee. It is commonly diagnosed in patients
between the ages of 20 and 45 years.1 GCT metastasizes
merely to the lungs in 2% of cases with unpredictable
behavior.
The sternum is infrequently affected by bone tumors.
Although uncommon, malignant neoplasms, such as chon-
drosarcoma, osteosarcoma, myeloma, and lymphoma, are
most likely to occur in this location.2 GCT of the sternum is
an even rarer condition,3,4 and only seven cases are well
documented in the literature.5-11 The present article
describes the clinical and cytogenetic aspects of an
additional case of GCT of the sternum occurring in a young
male and includes a discussion of the surgical treatment.
Case Report
A 32-year-old man presented with a sternal mass that had
shown progressive growth toward the suprasternal notch
over the previous ten months. He complained of local pain
that radiated to the cervical region and shoulders. Physical
examination showed a bony, tender, six cm large mass of
the manubrium (Figure 1A). The patient’s pain was
increased by palpation and elevation of his arms.
Plain radiographs showed an expansile osteolytic lesion of
the sternum. Computed tomography (CT) and magnetic
resonance imaging (MRI) demonstrated focal cortical bone
destruction, soft tissue extension and subchondral extension
in relation to the sternoclavicular joints. CT images confirmed
the osteolytic nature of the tumor and the absence of internal
mineralization. Post-contrast CT and MRI demonstrated
small foci that lacked the enhancement consistent with cystic
or hemorrhagic areas. MRI showed that the lesion was of
intermediate signal intensity on T1- and T2-weighted images
and included additional areas of high signal intensity on the
T2-weighted images (Figure 1D-E).
Histology from a prior biopsy performed at an outside
institution revealed a benign tumor composed of multi-
nucleated giant cells compatible with a GCT or a brown
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Figure 1 - A) Clinical aspect before and after surgery; B)
intraoperative aspect after sternum resection; C) intraoperative
aspect after reconstruction; and D) CT sagittal reconstruction
showing anterior focal cortical bone destruction and soft tissue
extension (arrow). In the post-contrast image, it is also possible
to identify a small region without contrast enhancement
(arrowhead). E) Axial T2-weighted MRI revealed intermediate
signal intensity predominance in the sternum giant cell tumor
(arrow), although regions of high signal intensity were also
present (arrowhead).
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tumor of hyperparathyroidism. Laboratory evaluation
revealed normal levels of calcium (1.25 MMol/l) and
parathyroid hormone (21 PG/ml), making the diagnosis of
a brown tumor highly unlikely.
The patient underwent resection of the manubrium with
wide margins and post-resection reconstruction with
GOREH DUALMESHH PLUS Biomaterial (W. L. Gore &
Associates, Inc., Flagstaff, USA) mesh fixed with polyester
separated stitches. Both the clavicles and the first ribs were
fixed to the mesh. Thoracic inspection showed no med-
iastinal or lung nodules. Disarticulation of the body-
manubrium joint was uneventful. A bilateral pectoralis
Figure 2 - A-D) Histological aspect of the lesion showing a triphasic aspect with giant, mononuclear and fusiform cells (B), bone (C) and
soft tissue (D) invasion of the tumor, and cystic formations (H&E, A - 4006, B - 2006, C - 1006, D - 1006); E) Cytogenetic analysis of a GCT
sample showing a 51, XY, 27, +9, del(10)(q23), add(11)(p15)62, 215, add(18)(q23), +mar1, +mar262, +mar3, +mar4, +mar5 karyotype.
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major flap covered the mesh and allowed skin closure
(Figure 1B-C).
Histological analysis of the resected specimen revealed
the presence of multinucleated giant cells, mononucleated
small cells and spindle cells with elongated nuclei without
atypias. Occasionally, more than 100 nuclei could be
perceived in the giant cells, a typical characteristic of GCT
(Figure 2A).
The tumor growth had induced extensive bone erosion
and focally infiltrated adjacent soft tissues (Figure 2B-C).
Blood-filled dilated spaces were seen, suggesting an
association with an aneurysmal bone cyst (Figure 2D).
Less than one typical mitotic figure was seen per ten high
power fields. Atypical mitosis, vascular invasion, and tumor
necrosis were not detected.
To allow for cytogenetic studies, a fresh GCT sample
(adjacent to areas of the tumor verified by frozen section)
was aseptically collected in the operating room and
processed as previously described.12 Cytogenetic analysis
was performed on 30 metaphases and showed a complex
complement characterized by the presence of numerous
marker chromosomes. The karyotype was denoted as 51,
XY, -7, +9, del(10)(q23), add(11)(p15)x2, -15, add(18)(q23),
+mar1, +mar262, +mar3, +mar4, +mar5 (Figure 2E).
DISCUSSION
In the seven previously presented cases and this
additional case, the median age of diagnosis is 48 years
(range: 28 to 74 years); this age is slightly higher than that of
GCT patients in general (Table 1).
Although imaging can strongly indicate GCT, a biopsy is
necessary for diagnosis. Biopsy is of particular importance
when the neoplasm affects an unusual location. The variety
of giant cell-containing bone tumors (including osteosar-
coma, chondroblastoma, and aneurysmal bone cysts) can
cause biopsies with small sampling or fine-needle aspira-
tions to be misleading.10 Even with larger tumor samples, it
may be difficult to distinguish between GCT and parathyr-
oid brown tumor, and it is necessary to examine specific
hormone, calcium, and phosphate serum levels.
There is no consensus regarding the optimal surgical
treatment of sternal GCT; interventions ranging from simple
curettage to wide resection have been proposed.9 Futani
et al. suggest that the initial treatment should involve
extended curettage followed by filling with bone cement
(Polimetilmetacrilate - PMMA). Because local recurrence
rates reach approximately 50% due to the locally aggressive
behavior of GCTs, more aggressive forms of surgery, such
as marginal or wide resection, should be considered.8,9
Futani et al. suggest that a prosthetic replacement is
needed after a subtotal sternectomy to protect the lungs,
heart, and main vessels as well as to restore functional
thoracic movement to prevent paradoxical respiration.9 As
described by Gonfiotti et al., we did not use a rigid
prosthetic replacement after the partial sternectomy. No
respiratory distress was observed in our patient.13
Three of the eight described cases affected the manu-
brium and were treated by subtotal sternectomy.
Reconstructions were performed with prosthetics in one
case, with nothing in one case and with a mesh in our case.
In the five cases that affected the body of the sternum, two
were treated with curettage and PMMA filling and three
with subtotal sternectomy and reconstruction (with a
prosthesis in two cases and fascia lata in one) (Table 1).
There are only limited data in the literature on chromo-
somal aberrations in GCT of the bone. Typically, this tumor
is characterized by a high frequency of telomeric fusion,
which has been implicated in the initiation of chromosomal
instability and tumorigenesis.14 Correspondingly, GTG-
banding analysis has demonstrated a more frequent
involvement of chromosomes 11p, 13p, 15p, 18p, 19p, and
21p in this process.15
Cytogenetic analysis of our sample showed a complex
karyotype characterized by the presence of clonal rearrange-
ments and numerous marker chromosomes. In the literature,
some clonal aberrations have been described.15-17 Most
notably, Bridge et al. demonstrated clonal structural translo-
cations involving 11p15 in more than one patient; this region
was also affected in our tumor sample.15 Sawyer et al.
described abnormal karyotypes with clonal telomeric fusions
involving the short arm of chromosome 11.18 In three of the
five cases studied, telomeric fusions of 11pter were appar-
ently the precursor lesions to the progression of sub-clones of
11p with structural chromosomal aberrations.
Sternal GCT is a very rare disease and should be treated
with partial sternectomy. Reconstruction may be done with
rigid or flexible materials depending on the stability of the
Table 1 - Reported cases of giant cell tumor (GCT) of the sternum.
Reference Gender
Age
(years) Symptom Location Size (cm) Surgery Reconstruction
Follow-up
(months)
Cytogenetic
study
Sundaram
et al., 1982
m 55 painless manubrium NA subtotal
sternectomy
none NA No
Bay et al.,
1999
f 49 pain manubrium 3.963.2 subtotal
sternectomy
prosthesis 60 Yes
Segawa et al.,
2004
m 55 pain body 3.563.0 curretage PMMA 12 No
Imai et al.,
2006
m 45 pain body 8.564.562.5 subtotal
sternectomy
prosthesis 12 No
Futani et al.,
2008
f 53 pain body 86462.5 curretage PMMA 84 No
Abate et al.,
2009
m 28 painful mass body 6.464.364.4 subtotal
sternectomy
prosthesis 5 No
Faria et al.,
2010
f 74 painful mass body 1267.564.5 subtotal
sternectomy
fascia lata 5 No
Current case m 32 painful mass manubrium 7,665,164,7 subtotal
sternectomy
Gore Dualmesh PlusH 10 Yes
Abbreviations: NA, data not available; PMMA, bone cement filling.
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chest wall. Biopsy is indispensable, and the ability to
differentiate between GCT and hyperparathyroidism
depends on blood sampling. Although no association has
been established between unfavorable outcomes and chro-
mosomal changes other than telomeric associations, the
frequent involvement of 11p15 in clonal rearrangements
suggests that chromosomal changes play an important role
in GCT initiation and progression. Whether this alteration is
associated with this particular tumor location requires
further investigation.
REFERENCES
1. Reid R, Banerjee SS, Sciot S. Giant cell tumor in: In: Fletcher CDM, Unni
KK, Mertens F, editors. World health organization classification of
tumors. Pathology and genetics of tumors of soft tissue and bone. 1st ed.
Lyon: IARC Press 2002;p.234-6.
2. Downey RJ, Huvos AG, Martini N. Primary and secondary malignancies
of the sternum. Semin Thorac Cardiovasc Surg. 1999;11:293-6.
3. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant cell tumor of
bone. J Bone Joint Surg Am. 1987;69:106-14.
4. Campanacci M. Giant cell tumor. In: Campanacci M, editor. Bone and
soft tissue tumors. 2nd ed.Wien: Springer-Verlag. 1999;p.99
5. Sundaram M, Martin SA, Johnson FE and Wolverson MK. Case report
198. Giant cell tumor of manubrium. Skeletal Radiol. 1982;8:225-7, doi:
10.1007/BF00355512.
6. Bay JO, Bignon YJ, Gros P, Jancovici R, Desangles F, Dubayle P, et al.
Giant cell tumor of the sternum. Report of a case with a 17q
isochromosome. Rev Rhum Engl Ed. 1999;66:49-52.
7. Segawa T, Kanamori M, Ohmori K, Nobukiyo M, Nogami S, Kimura T,
et al. Giant cell tumor of the sternum: a case report. J Orthop Sci.
2004;9:175-7, doi: 10.1007/s00776-003-0752-5.
8. Imai K, Minamiya Y, Saito H, Kawai H, Ito M, Ogawa J. Giant cell tumor
of the sternum. Jpn J Thorac Cardiovasc Surg. 2006;54:405-8, doi: 10.
1007/s11748-006-0017-2.
9. Futani H, Okumura Y, Fukuda Y, Fukunaga S, Hasegawa S, Yoshiya S.
Giant cell tumor of the sternum: a case report and review of the
literature. Anticancer Res. 2008;28:4117-20.
10. Abate E, Banki F, Hagen JA, Klipfel N. Giant cell tumor of the sternum.
Ann Thorac Surg. 2009;88:645-7, doi: 10.1016/j.athoracsur.2008.12.059.
11. Faria RA, Silva CM, Miziara JEA, Melo FY, Silva SRM, Viana CR. Giant
cell tumor of the sternum. J Bras Pneumol. 2010;36:517-20, doi: 10.1590/
S1806-37132010000400020.
12. Brassesco MS, Valera ET, Neder L, Castro-Gamero AM, Arruda D,
Machado HR, et al. Polyploidy in atypical grade II choroid plexus
papilloma of the posterior fossa. Neuropathology 2009;29:293-8.
13. Gonfiotti A, Santini PF, Campanacci D, Innocenti M, Ferrarello S,
Caldarella A, et al. Malignant primary chest-wall tumours: techniques of
reconstruction and survival. Eur J Cardiothorac Surg. 2010;38:39-45, doi:
10.1016/j.ejcts.2009.12.046.
14. Zheng MH, Siu P, Papadimitriou JM, Wood DJ, Murch AR. Telomeric
fusion is a major cytogenetic aberration of giant cell tumors of bone.
Pathology. 1999;31:373-8, doi: 10.1080/003130299104756.
15. Bridge JA, Neff JR, Mouron BJ. Giant cell tumor of bone. Chromosomal
analysis of 48 specimens and review of the literature. Cancer Genet
Cytogenet 1992;58:2–13.
16. Molenaar WM, Van den Berg E, Dolfin AC, Zorgdrager H, Hoekstra HJ.
Cytogenetics of fine needle aspiration biopsies of sarcomas. Cancer
Genet Cytogenet. 1995;84:27–31, doi: 10.1016/0165-4608(95)00068-2.
17. Sciot R, Dorfman H, Brys P, Dal Cin P, De Wever I, Fletcher CD, et al.
Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell
tumor of bone and combined lesions. A report from the CHAMP study
group. Mod Pathol. 2000;13:1206-10.
18. Sawyer JR, Goosen LS, Binz RL, Swanson CM, Nicholas RW. Evidence
for telomeric fusions as a mechanism for recurring structural aberrations
of chromosome 11 in giant cell tumor of bone. Cancer Genet Cytogenet.
2005;159:32-6, doi: 10.1016/j.cancergencyto.2004.09.001.
Giant Cell Tumor of the Sternum
Engel EE et al.
CLINICS 2011;66(8):1501-1504
1504
